Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis

NCT01933802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: intrathecal administration of autologous MSC-NP

Sponsor

Tisch Multiple Sclerosis Research Center of New York